Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging

Dullei Min, Angela Panoskaltsis-Mortari, Makoto Kuro-o, Georg A. Holländer, Bruce R. Blazar, Kenneth I. Weinberg

Research output: Contribution to journalArticle

144 Citations (Scopus)

Abstract

Age-related thymopoietic insufficiency has been proposed to be related to either defects in lymphohematopoietic progenitors or the thymic microenvironment. In this study,we examined whether keratinocyte growth factor (KGF), an epithelial cell-specific growth factor, could increase thymopoietic capacity in aged mice by restoration of the function of thymic epithelial cells (TECs). The thymic cellularity in KGF-treated aged mice increased about 4-fold compared to placebo-treated mice, resulting in an equivalent thymic cellularity to young mice. Enhanced thymopoiesis was maintained for about 2 months after a single course of KGF, and sustained improvement was achieved by administration of monthly courses of KGF. With the enhanced thymopoiesis after KGF treatment, the number of naive CD4 T cells in the periphery and T-cell-dependent antibody production improved in aged mice. KGF induced increased numbers of TECs and intrathymic interleukin-7 (IL-7) production and reorganization of cortical and medullary architecture. Furthermore, KGF enhanced thymopoiesis and normalized TEC organization in klotho (kl/kl) mice, a model of premature degeneration and aging, which displays thymopoietic defects. The result suggests that TEC damage is pathophysiologically important in thymic aging, and KGF therapy may be clinically useful in improving thymopoiesis and immune function in the elderly.

Original languageEnglish (US)
Pages (from-to)2529-2537
Number of pages9
JournalBlood
Volume109
Issue number6
DOIs
StatePublished - Mar 15 2007

Fingerprint

Fibroblast Growth Factor 7
Immunity
Aging of materials
Epithelial Cells
T-cells
Premature Aging
T-Lymphocytes
Interleukin-7
Defects
Restoration
Antibody Formation
Intercellular Signaling Peptides and Proteins
Placebos
Antibodies

ASJC Scopus subject areas

  • Hematology

Cite this

Min, D., Panoskaltsis-Mortari, A., Kuro-o, M., Holländer, G. A., Blazar, B. R., & Weinberg, K. I. (2007). Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. Blood, 109(6), 2529-2537. https://doi.org/10.1182/blood-2006-08-043794

Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. / Min, Dullei; Panoskaltsis-Mortari, Angela; Kuro-o, Makoto; Holländer, Georg A.; Blazar, Bruce R.; Weinberg, Kenneth I.

In: Blood, Vol. 109, No. 6, 15.03.2007, p. 2529-2537.

Research output: Contribution to journalArticle

Min, D, Panoskaltsis-Mortari, A, Kuro-o, M, Holländer, GA, Blazar, BR & Weinberg, KI 2007, 'Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging', Blood, vol. 109, no. 6, pp. 2529-2537. https://doi.org/10.1182/blood-2006-08-043794
Min, Dullei ; Panoskaltsis-Mortari, Angela ; Kuro-o, Makoto ; Holländer, Georg A. ; Blazar, Bruce R. ; Weinberg, Kenneth I. / Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging. In: Blood. 2007 ; Vol. 109, No. 6. pp. 2529-2537.
@article{e4cec38ae5c64c818adf7af1d09471f5,
title = "Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging",
abstract = "Age-related thymopoietic insufficiency has been proposed to be related to either defects in lymphohematopoietic progenitors or the thymic microenvironment. In this study,we examined whether keratinocyte growth factor (KGF), an epithelial cell-specific growth factor, could increase thymopoietic capacity in aged mice by restoration of the function of thymic epithelial cells (TECs). The thymic cellularity in KGF-treated aged mice increased about 4-fold compared to placebo-treated mice, resulting in an equivalent thymic cellularity to young mice. Enhanced thymopoiesis was maintained for about 2 months after a single course of KGF, and sustained improvement was achieved by administration of monthly courses of KGF. With the enhanced thymopoiesis after KGF treatment, the number of naive CD4 T cells in the periphery and T-cell-dependent antibody production improved in aged mice. KGF induced increased numbers of TECs and intrathymic interleukin-7 (IL-7) production and reorganization of cortical and medullary architecture. Furthermore, KGF enhanced thymopoiesis and normalized TEC organization in klotho (kl/kl) mice, a model of premature degeneration and aging, which displays thymopoietic defects. The result suggests that TEC damage is pathophysiologically important in thymic aging, and KGF therapy may be clinically useful in improving thymopoiesis and immune function in the elderly.",
author = "Dullei Min and Angela Panoskaltsis-Mortari and Makoto Kuro-o and Holl{\"a}nder, {Georg A.} and Blazar, {Bruce R.} and Weinberg, {Kenneth I.}",
year = "2007",
month = "3",
day = "15",
doi = "10.1182/blood-2006-08-043794",
language = "English (US)",
volume = "109",
pages = "2529--2537",
journal = "Blood",
issn = "0006-4971",
publisher = "American Society of Hematology",
number = "6",

}

TY - JOUR

T1 - Sustained thymopoiesis and improvement in functional immunity induced by exogenous KGF administration in murine models of aging

AU - Min, Dullei

AU - Panoskaltsis-Mortari, Angela

AU - Kuro-o, Makoto

AU - Holländer, Georg A.

AU - Blazar, Bruce R.

AU - Weinberg, Kenneth I.

PY - 2007/3/15

Y1 - 2007/3/15

N2 - Age-related thymopoietic insufficiency has been proposed to be related to either defects in lymphohematopoietic progenitors or the thymic microenvironment. In this study,we examined whether keratinocyte growth factor (KGF), an epithelial cell-specific growth factor, could increase thymopoietic capacity in aged mice by restoration of the function of thymic epithelial cells (TECs). The thymic cellularity in KGF-treated aged mice increased about 4-fold compared to placebo-treated mice, resulting in an equivalent thymic cellularity to young mice. Enhanced thymopoiesis was maintained for about 2 months after a single course of KGF, and sustained improvement was achieved by administration of monthly courses of KGF. With the enhanced thymopoiesis after KGF treatment, the number of naive CD4 T cells in the periphery and T-cell-dependent antibody production improved in aged mice. KGF induced increased numbers of TECs and intrathymic interleukin-7 (IL-7) production and reorganization of cortical and medullary architecture. Furthermore, KGF enhanced thymopoiesis and normalized TEC organization in klotho (kl/kl) mice, a model of premature degeneration and aging, which displays thymopoietic defects. The result suggests that TEC damage is pathophysiologically important in thymic aging, and KGF therapy may be clinically useful in improving thymopoiesis and immune function in the elderly.

AB - Age-related thymopoietic insufficiency has been proposed to be related to either defects in lymphohematopoietic progenitors or the thymic microenvironment. In this study,we examined whether keratinocyte growth factor (KGF), an epithelial cell-specific growth factor, could increase thymopoietic capacity in aged mice by restoration of the function of thymic epithelial cells (TECs). The thymic cellularity in KGF-treated aged mice increased about 4-fold compared to placebo-treated mice, resulting in an equivalent thymic cellularity to young mice. Enhanced thymopoiesis was maintained for about 2 months after a single course of KGF, and sustained improvement was achieved by administration of monthly courses of KGF. With the enhanced thymopoiesis after KGF treatment, the number of naive CD4 T cells in the periphery and T-cell-dependent antibody production improved in aged mice. KGF induced increased numbers of TECs and intrathymic interleukin-7 (IL-7) production and reorganization of cortical and medullary architecture. Furthermore, KGF enhanced thymopoiesis and normalized TEC organization in klotho (kl/kl) mice, a model of premature degeneration and aging, which displays thymopoietic defects. The result suggests that TEC damage is pathophysiologically important in thymic aging, and KGF therapy may be clinically useful in improving thymopoiesis and immune function in the elderly.

UR - http://www.scopus.com/inward/record.url?scp=33947192136&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33947192136&partnerID=8YFLogxK

U2 - 10.1182/blood-2006-08-043794

DO - 10.1182/blood-2006-08-043794

M3 - Article

C2 - 17138819

AN - SCOPUS:33947192136

VL - 109

SP - 2529

EP - 2537

JO - Blood

JF - Blood

SN - 0006-4971

IS - 6

ER -